Drug intelligence / Profile preview

unoprostone isopropyl

Development stage
Phase 3
Lead developer
Mallinckrodt
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Ophthalmic
01

Overview

Unoprostone isopropyl is a synthetic docosanoid and a structural analogue of an inactive biosynthetic cyclic derivative of arachidonic acid (13,14-dihydro-15-keto-prostaglandin F2α). It acts as a prodrug that, upon ocular administration, lowers intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. The drug primarily increases the outflow of aqueous humor through the trabecular meshwork and possibly via the uveoscleral pathway. Its mechanism may involve stimulation of calcium (Ca2+)-activated BK channels and ClC-2 chloride channels in the trabecular meshwork. Unoprostone isopropyl does not significantly affect aqueous humor production or systemic cardiovascular/pulmonary function[1][2][3][4][5][8].

Brand names
Rescula
Other names
isopropyl unoprostoneeesculaisopropyl 20-ethyl-9alpha,11alpha-dihydroxy-15-keto-cis-delta-5-prostanoate
02

Targets

CLCN2 (Chloride channel protein CIC-2)

Beyond the preview

Go deeper on unoprostone isopropyl.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on unoprostone isopropyl.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call